Complement biomarkers during iptacopan treatment - Authors' reply.
Saved in:
| Title: | Complement biomarkers during iptacopan treatment - Authors' reply. |
|---|---|
| Authors: | Kavanagh D; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; National Renal Complement Therapeutics Centre, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK. Electronic address: david.kavanagh@newcastle.ac.uk., Bomback AS; David Koch Jr Glomerular Kidney Center, Columbia University Irving Medical Center, New York, NY, USA., Vivarelli M; Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Nester CM; Stead Family Children's Hospital-University of Iowa, Iowa City, IA, USA., Smith RJH; Carver College of Medicine, University of Iowa, Iowa City, IA, USA. |
| Source: | Lancet (London, England) [Lancet] 2026 Mar 28; Vol. 407 (10535), pp. 1235-1236. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
